Evaluation of Multiple Subgingival Irrigations.

NCT ID: NCT03432975

Last Updated: 2019-07-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-12-18

Study Completion Date

2019-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will be conducted at the Department of Periodontology, Cliniques universitaires Saint Luc. Patients diagnosed with Generalized Chronic Periodontitis (GChP) based on the current classification of the American Academy of Periodontology will be included. Detailed medical, periodontal and dental history will be obtained. Those who will fulfill the inclusion/exclusion criteria will be invited to participate in the study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will be conducted at the Department of Periodontology, Cliniques universitaires Saint Luc. The patients will be informed in detail of the nature and course of study, and will sign informed consent prior to engagement in the study. Patients diagnosed with GChP based on the current classification of the American Academy of Periodontology will be included. Detailed medical, periodontal and dental history will be obtained. Those who will fulfill the inclusion/exclusion criteria will be invited to participate in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periodontitis, Adult

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

20 patients (=40 half-mouth); 20 half-mouth per group
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Povidone Iodine 10%

The side of the mouth receiving the subgingival irrigations of povidone iodine.

Group Type EXPERIMENTAL

Povidone-Iodine 10%

Intervention Type DRUG

The side of the mouth receiving the subgingival irrigations of povidone iodine 10% (test group)

Sterile saline solution

The other side of the mouth will be irrigated with a sterile saline solution.

Group Type PLACEBO_COMPARATOR

Saline Solution

Intervention Type DRUG

The other side of the mouth will be irrigated with a sterile saline solution (control group)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Povidone-Iodine 10%

The side of the mouth receiving the subgingival irrigations of povidone iodine 10% (test group)

Intervention Type DRUG

Saline Solution

The other side of the mouth will be irrigated with a sterile saline solution (control group)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 30 years of age
* At least 15 teeth (excluding third molars and teeth with advanced decay indicated for extraction)
* Any history of periodontal treatment in the previous 6 months
* No removable prosthesis
* A minimum of 6 teeth with at least one site each with periodontal probing depth (PPD) and clinical attachment level (CAL) ≥5 mm
* At least 30% of the sites with PPD and CAL ≥4 mm and bleeding on probing (BOP)

Exclusion Criteria

* Any sensitivity or allergy to any of the products that will be used in the study
* Thyroid dysfunction
* Systemic disease (ASA II or more)
* Need for antibiotic pre-medication for routine dental therapy
* Antibiotic therapy in the previous 3 months
* Pregnancy and breastfeeding
* Current smokers (more than 5 cigarettes a day)
Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cliniques Universitaires Saint-Luc

Brussels, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Selena Toma, Parodontologist

Role: CONTACT

00322764 ext. 5714

Selma Kessler, Dentist

Role: CONTACT

00322764 ext. 5714

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Selena Toma, Parodontologist

Role: primary

00322764 ext. 5714

Selma Kessler, Dentist

Role: backup

00322764 ext. 5714

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017/06NOV/503

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Stannous Fluoride and Gingivitis
NCT05326373 COMPLETED NA
Surgical Treatment of Peri-implantitis
NCT01857804 COMPLETED PHASE4